Table of Contents
As the global population ages, understanding the pharmacokinetics of medications in elderly patients becomes increasingly important. Geriatric pharmacokinetics involves studying how drugs are absorbed, distributed, metabolized, and excreted in older adults. These processes can differ significantly from younger populations, affecting drug efficacy and safety.
Introduction to Geriatric Pharmacokinetics
Pharmacokinetics describes what the body does to a drug. In older adults, physiological changes can alter each phase of this process. Recognizing these changes helps clinicians optimize medication regimens and reduce adverse effects.
Absorption
Absorption refers to how drugs enter the bloodstream from the site of administration. In elderly patients, gastric pH tends to increase, making the stomach less acidic. This change can affect the solubility and absorption of certain drugs, such as calcium and iron supplements.
Gastrointestinal motility also decreases with age, which may delay drug absorption. Additionally, reduced splanchnic blood flow can impact the initial distribution of drugs post-absorption.
Distribution
Distribution involves the dispersion of drugs throughout body tissues. In older adults, body composition changes significantly:
- Decreased total body water
- Reduced lean body mass
- Increased body fat
These changes influence drug distribution. For example, lipophilic drugs like diazepam may have a prolonged half-life due to increased fat stores, leading to prolonged effects. Conversely, hydrophilic drugs may have higher plasma concentrations because of decreased total body water.
Metabolism
The liver is central to drug metabolism, primarily through phase I and phase II reactions. In the elderly, hepatic blood flow decreases by approximately 40%, which can reduce the clearance of many drugs.
Phase I reactions, such as oxidation and reduction, tend to decline more significantly than phase II conjugation reactions. As a result, drugs metabolized predominantly via phase I pathways, like propranolol, may accumulate, increasing the risk of toxicity.
Excretion
Renal excretion is often the most affected pharmacokinetic process in older adults. Glomerular filtration rate (GFR) declines by about 1% annually after age 40, leading to decreased clearance of renally-excreted drugs such as digoxin, aminoglycosides, and certain antibiotics.
Estimating renal function using serum creatinine alone can be misleading in the elderly. Equations like the Cockcroft-Gault formula are preferred for dose adjustments.
Clinical Implications
Understanding these pharmacokinetic changes helps clinicians individualize therapy in older adults. Dose adjustments, careful monitoring, and awareness of altered drug responses can minimize adverse effects and improve therapeutic outcomes.
Summary of Key Changes
- Absorption: Delayed gastric emptying, increased pH
- Distribution: Increased fat, decreased water and lean mass
- Metabolism: Reduced hepatic blood flow, altered phase I reactions
- Excretion: Declined renal function, decreased clearance
By recognizing these changes, healthcare providers can optimize medication use and improve health outcomes in the aging population.